Diagnostic Performance of Radiolabelled FAPI Versus [18F]FDG PET Imaging in Hepato-Pancreato-Biliary Oncology: A Systematic Review and Meta-Analysis
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26051978 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Rutger B Henrar und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Amsterdam UMC Location Vrije Universiteit Amsterdam, de Boelelaan 1117, 1081 HV Amsterdam, The Netherlands. Hauptthemen laut MEDLINE: Fluorodeoxyglucose F18, Liver Neoplasms, Positron-Emission Tomography, Pancreatic Neoplasms. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: KWF Dutch Cancer Society.
Abstract (Originalsprache)
Radiolabelled fibroblast activation protein inhibitor (FAPI) tracers have the potential to overcome the limitations of 2-deoxy-2-[18F]fluoro-D-glucose ([18F]FDG) and improve the diagnosis and staging of hepato-pancreato-biliary (HPB) cancers. This study aims to compare the diagnostic performance of radiolabelled FAPI versus [18F]FDG PET imaging in HPB cancers. A systematic search of PubMed, Embase, Web of Science and Cochrane Library was performed to identify eligible studies on the diagnostic performance of FAPI PET for primary HPB tumours (hepatocellular carcinoma (HCC), pancreatic cancer (PC) and biliary tract cancer (BTC)) and for liver metastases of gastrointestinal origin. The diagnostic performance was defined as a combination of detection rate and semi-quantitative tracer uptake. A random-effects model was used to calculate the risk differences. In total, 28 studies were included. Histopathology was the reference standard for the primary tumour in 26 studies (93%). The detection rate of radiolabelled FAPI in comparison to [18F]FDG was significantly higher in HCC (0.33, 95% CI: 0.20–0.47 and 0.34, 95% CI: 0.23–0.45) and BTC (0.27, 95% CI: 0.11–0.43 and 0.28, 95% CI: 0.08–0.48), in the patient- and lesion-based analyses, respectively. In PC, no differences were observed. Radiolabelled FAPI outperformed [18F]FDG in the lesion-based detection of lymph node, liver and extra-hepatic metastases. In all HPB cancers, the mean SUVmax was significantly higher with radiolabelled FAPI compared to [18F]FDG. Molecular imaging with FAPI PET seems to have several benefits over [18F]FDG PET in HPB cancer diagnostics, with an overall higher tracer uptake, and higher detection rates in HCC and BTC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Surgery, Amsterdam UMC Location Vrije Universiteit Amsterdam, de Boelelaan 1117, 1081 HV Amsterdam, The Netherlands.
- Cancer Center Amsterdam, Imaging and Biomarkers, Van der Boechorststraat 6B, 1081 BT Amsterdam, The Netherlands.
- Department of Surgery, Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, The Netherlands.
- Medical Library, Vrije Universiteit Amsterdam, de Boelelaan 1118, 1081 HV Amsterdam, The Netherlands.
- Department of Radiology, Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, The Netherlands.
- Department of Medical Imaging, Radboud University Medical Center, Geert Grootplein Zuid 10, 6525 GA Nijmegen, The Netherlands.
ORCID-Profile: Rutger B Henrar, Floris A Vuijk, Lioe-Fee de Geus-Oei
Förderung
- KWF Dutch Cancer Society
Zitieren
APA
Henrar, R. B., Vuijk, F. A., Burchell, G. L., van Dieren, S., de Geus-Oei, L. F., Kazemier, G., Vahrmeijer, A. L., Oprea-Lager, D. E., & Swijnenburg, R. J. (2025). Diagnostic Performance of Radiolabelled FAPI Versus [18F]FDG PET Imaging in Hepato-Pancreato-Biliary Oncology: A Systematic Review and Meta-Analysis. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26051978
Vancouver
Henrar RB, Vuijk FA, Burchell GL, van Dieren S, de Geus-Oei LF, Kazemier G, et al. Diagnostic Performance of Radiolabelled FAPI Versus [18F]FDG PET Imaging in Hepato-Pancreato-Biliary Oncology: A Systematic Review and Meta-Analysis. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26051978
BibTeX
@article{Henrar2025,
author = {Henrar, Rutger B and Vuijk, Floris A and Burchell, George L and van Dieren, Susan and de Geus-Oei, Lioe-Fee and Kazemier, Geert and Vahrmeijer, Alexander L and Oprea-Lager, Daniela E and Swijnenburg, Rutger-Jan},
title = {Diagnostic Performance of Radiolabelled FAPI Versus [18F]FDG PET Imaging in Hepato-Pancreato-Biliary Oncology: A Systematic Review and Meta-Analysis},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26051978}
}
EUVIMED